Inquirer on MSN3d
US approves 1st fast-acting insulin biosimilar for diabetes
The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...
Biocon Biologics to supply Insulin Aspart drug substance to Civica for US market
Biocon Biologics partners with Civica to enhance access to Insulin Aspart in the US, no tech transfer involved.
6 Benefits of Metformin (Besides Weight Loss)
Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...
The Punch on MSN3d
NAFDAC alerts Nigerians on circulation of substandard insulin syringes
The National Agency for Food and Drug Administration and Control has raised the alarm over the illegal circulation and ...
CA insulin
Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...
How Ozempic and other GLP-1 agonist drugs turn down 'food noise' and cravings
People on Ozempic and other GLP-1 agonist drugs commonly report they no longer have constant, incessant thoughts about food.
Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US
Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will ...
The Punch on MSN12h
Artificial sweeteners linked to insulin spike, artery damage
The study states that artificial sweeteners, also known as non-nutritive sweeteners, have long been used as a low-calorie ...
California Made a Big Bet on Producing Its Own Insulin, But There’s No ‘Date Certain’ for Delivery
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
The tale of the doctor in the Bronx and the Gila monster
The story of one huge advance in health care shows why public investment in science is critical and why proposed cuts are ...